Effect of the mGlu2 positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset-Reference-Cited by-同舟云学术

Effect of the mGlu2 positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset

Published:2021-01 Issue:1 Volume:128 Page:73-81
ISSN:0300-9564
Container-title:Journal of Neural Transmission
language:en
Short-container-title:J Neural Transm

Author:

Frouni Imane^ORCID,Kwan Cynthia^ORCID,Nuara Stephen G.,Belliveau Sébastien^ORCID,Kang Woojin,Hamadjida Adjia,Bédard Dominique,Gourdon Jim C.,Huot Philippe^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1007/s00702-020-02287-8.pdf

Reference61 articles.

1. Alvir JM, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA (1993) Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. N Engl J Med 329(3):162–167. https://doi.org/10.1056/NEJM199307153290303

2. Ballanger B, Strafella AP, van Eimeren T, Zurowski M, Rusjan PM, Houle S, Fox SH (2010) Serotonin 2A receptors and visual hallucinations in Parkinson disease. Arch Neurol 67(4):416–421. https://doi.org/10.1001/archneurol.2010.35

3. Beaudry F, Huot P (2020) The MPTP-lesioned marmoset model of Parkinson’s disease: proposed efficacy thresholds that may potentially predict successful clinical trial results. J Neural Transm (Vienna) 127(10):1343–1358. https://doi.org/10.1007/s00702-020-02247-2

4. Blanpied TA, Clarke RJ, Johnson JW (2005) Amantadine inhibits NMDA receptors by accelerating channel closure during channel block. J Neurosci 25(13):3312–3322. https://doi.org/10.1523/JNEUROSCI.4262-04.2005

5. Borgohain R, Szasz J, Stanzione P, Meshram C, Bhatt MH, Chirilineau D, Stocchi F, Lucini V, Giuliani R, Forrest E, Rice P, Anand R, Study 018 Investigators (2014) Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson’s disease. Mov Disord 29(10):1273–1280. https://doi.org/10.1002/mds.25961

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoradiographic labelling of metabotropic glutamate type 2/3 receptors in the hemi-parkinsonian rat brain;Journal of Chemical Neuroanatomy;2024-07

2. Effect of the mGlu₂ positive allosteric modulator biphenyl‐indanone A as a monotherapy and as adjunct to a low dose of L‐DOPA in the MPTP‐lesioned marmoset;European Journal of Neuroscience;2024-06-27

3. Effect of mGluR2 and mGluR2/3 activators on parkinsonism in the MPTP-lesioned non-human primate;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-20

4. Positive allosteric mGluR2 modulation with BINA alleviates dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-11

5. Activation of mGlu2/3 receptors with the orthosteric agonist LY-404,039 alleviates dyskinesia in experimental parkinsonism;Behavioural Pharmacology;2024-03-29